The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The purpose of this study is to investigate the ability of budesonide, given during episodes of troublesome lung symptoms to reduce further symptoms in infants and young children at risk of developing asthma
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
up to 6 Months (Child)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Children of asthmatic mothers form the COPSAC birth cohort study
Children born more than 4 weeks preterm
children with other systemic illness that atopy/allergy
Children requiring mechanical ventilation at any time since birth.